Drug combination highly effective in children with standard-and high-risk APL
- OPACC
- Nov 12, 2021
- 1 min read
A clinical trial has found that the combination of all-trans retinoic acid, which is a metabolite of vitamin A, and arsenic trioxide is highly effective in children with standard- and high-risk acute promyelocytic leukemia, or APL.
Comments